All 3 have dynamic stories.
I really like SIPC because they have a product that is most familiar and accessible to the masses: Beer.
If someone were wanting to experiment for the first time with anything associated with marijuana or hemp, and have the option to do so through a common thread within their social rituals, they will likely start there. Hemp / CBD Beer.
So SIPC is for the general masses.
CANB has the association with professional doctors. Their CBD tinctures, sprays, and capsules are distributed through a network of medical professionals.
So I see CANB being more for the proper, self conscious, clean imaged crowd, looking for a “legitimate” medical way to partake.
I see VATE having the association with the spiritual, yoga, vegan, hipster, new age crowd. They are the group who are into health and wellness as a lifestyle. Of course the general masses drink tea and coffee, but the difference is VATE’s customer profile will integrate their products into daily routines vs. SIPC’s customer profile integrating into more of a social ritual. The health and wellness crowd isn’t exactly your beer drinking kind of crowd.
Being invested in all three is a good diversified strategy as each hits different customer profiles.
As for how the investor chooses to spread their holdings, likely depends what kind of customer profile they see themselves fitting within.
For what it’s worth, in order of total dollar value invested from top to bottom, I’m in CANB, SIPC, then VATE.
However, I like the way the story can play out with SIPC the most.
Go CANB, SIPC, and VATE!
Rec
News 
Market Data 
Discover 
